ArticleAntimicrobial agents and chemotherapy2015

A novel tricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor, GRL-0739, effectively inhibits the replication of multidrug-resistant HIV-1 variants and has a desirable central nervous system penetration property in vitro.

Masayuki Amano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.